Q1 2015 13F Holders as of 3/31/2015
-
Type / Class
-
Equity / Common Stock, $0.0001 par value per share
-
Shares outstanding
-
106M
-
Number of holders
-
112
-
Total 13F shares, excl. options
-
24.2M
-
Shares change
-
-525K
-
Total reported value, excl. options
-
$321M
-
Value change
-
-$7.61M
-
Put/Call ratio
-
0.25
-
Number of buys
-
50
-
Number of sells
-
-55
-
Price
-
$13.28
Significant Holders of Sarepta Therapeutics, Inc. - Common Stock, $0.0001 par value per share (SRPT) as of Q1 2015
152 filings reported holding SRPT - Sarepta Therapeutics, Inc. - Common Stock, $0.0001 par value per share as of Q1 2015.
Sarepta Therapeutics, Inc. - Common Stock, $0.0001 par value per share (SRPT) has 112 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 24.2M shares
of 106M outstanding shares and own 22.89% of the company stock.
Largest 10 shareholders include COLUMBIA WANGER ASSET MANAGEMENT LLC (3.27M shares), VANGUARD GROUP INC (2.42M shares), PERCEPTIVE ADVISORS LLC (2.2M shares), STATE STREET CORP (2.19M shares), Point72 Asset Management, L.P. (1.7M shares), BlackRock Fund Advisors (1.56M shares), FMR LLC (1.26M shares), BlackRock Institutional Trust Company, N.A. (1.17M shares), PointState Capital LP (750K shares), and BlackRock Advisors LLC (605K shares).
This table shows the top 112 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.